









Rapid testing leads to the underestimation of the scrapie prevalence in an affected sheep 1 
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To obtain a more detailed understanding of the prevalence of classical scrapie 23 
infections in a heavily affected German sheep flock (composed of 603 sheep and 6 goats), we 24 
analysed 169 sheep and 6 goats that carried the genotypes susceptible to the disease and that 25 
were therefore culled following discovery of the index case. The initial tests were performed 26 
using the Biorad TeSeE ELISA and reactive results were verified by official confirmatory 27 
methods (OIE-immunoblot and/or immunohistochemistry (IHC)) to demonstrate the 28 
deposition of scrapie-associated PrPSc in the brain stem (obex). This approach led to the 29 
discovery of 40 additional subclinically scrapie-infected sheep. Furthermore, peripheral 30 
lymphatic tissue samples of the 129 sheep and six goats with a negative CNS result were 31 
examined by IHC in order to identify any preclinical infections which had not already spread 32 
to the central nervous system (CNS). Using this approach we found 13 additional sheep with 33 
PrPSc depositions in the gut-associated lymph nodes (GALT) as well as in the enteric nervous 34 
system. Moreover, in most of these cases PrPSc was also deposited in the spleen and in the 35 
retropharyngeal and superficial cervical lymph nodes. Taken together, these results show a 36 
30.3% infection prevalence in this scrapie-affected flock. Almost 7.4% of the infected animals 37 
harboured PrPSc exclusively in the peripheral lymphatic tissue and were therefore missed by 38 
the currently used testing strategy.  39 
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1. Introduction 43 
Scrapie belongs to the transmissible spongiform encephalopathies (TSE) of sheep and 44 
goats and is characterised by the accumulation of an abnormally folded isoform (PrPSc) of the 45 
cellular prion protein (PrPC). Incubation times vary between a few months and several years 46 
depending on the infectious dose and route, the particular scrapie strain and the genotype and 47 










age of the recipient animal (summarised in Detwiler and Baylis, 2003) According to the prion 48 
hypothesis (Prusiner et al., 1982), abnormally folded PrPSc represents the causative infectious 49 
agent itself, the ‘prion’. However, the existence of different strains remains as yet 50 
unexplained. PrPSc is partially protease resistant, insoluble in detergents (as a consequence of 51 
an increased β-sheet content which increases its hydrophobicity) and forms scrapie-associated 52 
fibrils (Diringer et al., 1983; Hope et al., 1986; Oesch et al., 1985). These criteria form the 53 
basis for the demonstration of PrPSc as a diagnostic marker. 54 
Amino acid polymorphisms at positions 136, 154 and 171 of the prion protein 55 
determine the susceptibility of sheep to classical scrapie. Alleles on the PrP gene encoding 56 
alanine/arginine/arginine (PrPARR) are associated with the lowest level of susceptibility, 57 
alleles encoding valine/arginine/glutamine (PrPVRQ) with the highest susceptibility, 58 
particularly if present in homozygous animals (Goldmann et al., 1990; Hunter, 1996; Hunter 59 
et al., 1997). The PrP genotype of sheep has a strong effect on the scrapie pathogenesis in 60 
sheep. While no, or only minor, traces of PrPSc depositions can be found in the peripheral 61 
lymphatic tissues (e.g., spleen, tonsils, retropharyngeal lymph nodes, gut-associated lymph 62 
nodes) of sheep carrying at least one PrPARR allele, PrPVRQ/VRQ and PrPARQ/ARQ carriers can 63 
show PrPSc accumulations in these lymphatic tissues as early as a few months after the 64 
infection (van Keulen et al., 1996 & 2002; Andreoletti et al., 2000; Jeffrey et al., 2002; Ersdal 65 
et al., 2005). Preclinical accumulation of PrPSc in lymphoreticular tissues of sheep therefore 66 
provides an opportunity for an in-vivo diagnosis based on biopsy samples of the tonsils 67 
(Schreuder et al., 1998), the third eyelid (O'Rourke et al., 2002) or the rectum (Gonzalez et 68 
al., 2006; Espenes et al., 2006). 69 
The gastrointestinal tract, in particular the gut-associated lymphoid tissues (GALT), is 70 
regarded as the major route of entry for natural scrapie (Hadlow et al., 1982; Heggebo et al., 71 
2000). The earliest accumulation of PrPSc can be found in the ileal Peyer’s patches (IPP) and 72 
in the draining mesenteric lymph nodes (Andreoletti et al., 2000). From there, prions may 73 










spread to other lymphatic tissues, which are not part of the GALT, resulting in a widespread 74 
distribution of disease-specific PrP deposition in the lymphoreticular system at relatively 75 
early stages of infection (Andreoletti et al., 2000; Heggebo et al., 2002; van Keulen et al., 76 
2002). Neuroinvasion appears to start at the enteric nervous system (ENS) followed by a 77 
centripetal and retrograde spread via sympathetic and parasympathetic efferent fibres of the 78 
autonomic nervous system to the spinal cord and to the medulla oblongata (van Keulen et al., 79 
2000).  80 
The aim of the study was to analyse the prevalence of preclinical scrapie in a cohort of 81 
susceptible sheep that were compulsorily culled after the detection of scrapie in the flock. For 82 
this purpose LRS and the peripheral nervous system samples were examined with particular 83 
attention paid to animals which were tested negative in the initial rapid test on the brain stem.  84 
 85 
2. Materials and Methods 86 
2.1. Sheep and goats 87 
All 169 German Blackheaded Mutton-Merino crossbreed sheep and 6 fawn goats 88 
belonged to a single flock (n=603) in Saxony-Anhalt in which an outbreak of classical scrapie 89 
occurred in December 2003.  90 
 91 
2.2. TSE rapid testing 92 
Brain stem samples from the obex region were examined using the Biorad TeSeE 93 
ELISA rapid test (Biorad, Munich, Germany) following the manufacturer’s instructions. 94 
 95 
2.3. Genotyping 96 
Sheep were genotyped as described previously (Lühken et al., 2004). 97 
 98 
2.4. Histopathology and immunohistochemistry  99 










With some modifications, tissue samples were processed as described previously 100 
(Hardt et al., 2000). In short, all tissue samples were fixed in 4% buffered formalin, treated 101 
for one hour with 98% formic acid, rinsed for 40 minutes in tap water, embedded in paraffin, 102 
sectioned at 3-4 µm and stained with haematoxylin and eosin. 103 
The avidin-biotin-complex (ABC) method was used for PrP-IHC. This involved the 104 
paraffin wax tissue sections being mounted on superfrost plus slides (Menzel-Gläser, 105 
Braunschweig, Germany) and rehydrated. The subsequent pretreatment included incubation 106 
of the slides in 98% formic acid for 15 minutes, a 5-minute rinse in tap water, inhibition of the 107 
endogenous peroxidase activity with 3% H2O2 (Merck, Darmstadt, Germany) in methanol for 108 
30 minutes, followed by 15 minutes digestion with proteinase K (4µg/ml, Boehringer, 109 
Mannheim, Germany) at 37 °C. The primary monoclonal antibody (mab) L 42, which binds to 110 
an epitope of amino acid 145-163 of ovine PrP, was applied at a dilution of 1:250 (Harmeyer 111 
et al., 1998) in Tris-buffered saline (TBS) containing 10 % goat serum and incubated 112 
overnight at 4°C. Negative control sections were treated with a monoclonal antibody against 113 
GP5 of the Porcine Respiratory and Reproductive Syndrome virus (Weiland et al., 1999). As a 114 
secondary (link) antibody, biotinylated goat anti-mouse antiserum (Vector Laboratories, 115 
Burlingame, CA, USA) was incubated on the sections in a 1:200 dilution for 30 minutes at 116 
room temperature. Immunodetection was amplified using Vector ABC-elite avidin-117 
horseradish peroxidase/biotin complex (Vector laboratories; Peterborough, UK). The slides 118 
were finally developed in DAB (diaminobenzidintetrahydrochloride) (Fluka Feinchemikalien, 119 
Neu Ulm, Germany) and counterstained with Mayer`s haematoxylin. All sections were 120 
examined using light microscopy.  121 
All positive results were verified using mab 2G11 binding to the epitope 146-182 of 122 
ovine PrP (Institut Pourquier, Montpellier, France) diluted 1:250 in TBS with 10 % goat 123 
serum. 124 
 125 










3. Results 126 
All 175 animals examined in this study came from a flock of 603 German Blackhead 127 
Mutton-Merino crossbreed sheep and six fawn goats which was kept in Saxony-Anhalt in 128 
Germany. The outbreak of classical scrapie was first recognised through TSE rapid testing in 129 
two fallen stock sheep. After the flock was quarantined and monitored, 10 more clinical cases 130 
of scrapie were identified. According to the EU 999/2001 regulation, all animals in the flock 131 
were genotyped with regard to codons 136, 154 and 171 of the sheep PrP gene and all 132 
genetically highly TSE-susceptible animals (169 sheep and six goats) were killed. The 133 
necropsy was carried out immediately after the death of the animals and a wide range of 134 
tissues of the central and peripheral nervous system as well as of the lymphoreticular system 135 
(LRS) was taken. Obex samples from these animals were subsequently TSE rapid tested using 136 
the Biorad TeSeE assay. Reactive results were obtained in another 40 of the 169 sheep and 137 
the TSE diagnosis in these cases was confirmed by using the OIE- approved methods, SAF-138 
immunoblot and/or IHC. Table 1 shows an overview of relevant data of all sheep investigated. 139 
All 135 animals with a negative rapid test result on the obex region were more closely 140 
examined by IHC to detect PrPSc accumulations in the peripheral nervous and lymphoreticular 141 
system using a hierarchical approach, as illustrated in Figure 1. In a first step the five most 142 
likely sites of entry for the agent were analysed. In cases where there was a total absence of 143 
PrPSc depositions in the samples, the animals were considered to be completely negative and 144 
no further studies were undertaken. However, if there was a positive result in one of the five 145 
tissues, the investigation was extended to several parts of the peripheral nervous system as 146 
well as to the lymphoreticular system. 147 
PrPSc was not found to be present in any of the initially investigated tissues of the six 148 
goats. However, PrPSc was found to be present in the lymphoreticular system of 13 of the 129 149 
investigated sheep. Table 2 summarises the results for all animals with a clear PrPSc-150 
immunolabelling.  151 










PrPSc was discovered in the lymphoreticular system in most animals and in particular 152 
in the head-associated lymph nodes (i.e., tonsils, retropharyngeal or mandibular lymph 153 
nodes). Interestingly, two sheep showed a strong staining reaction in these non-GALT 154 
lymphoid tissues (Figure 2C), but not in the GALT. Additionally, a PrPSc accumulation in the 155 
lymphoid follicles of the third eyelid was only apparent in the two sheep with the most 156 
widespread PrPSc distribution in the lymphoreticular system. As the rectum samples examined 157 
did not totally comply with the proposed diagnostic requirements (i.e. too low a number of 158 
follicles), the absence of PrPSc staining in any of the preclinically affected sheep at this site 159 
should be interpreted cautiously. 160 
Only a sparse immunolabelling was found in the peripheral nervous system. While 11 161 
sheep showed a strong PrPSc immunolabelling in the enteric nervous system of the distal 162 
ileum (Fig. 2A), only six of these sheep showed a detectable amount of PrPSc in the coeliac 163 
and mesenteric ganglion complex (Fig. 2B). Three of these sheep showed an additional PrP-164 
immunostaining in the ENS of the rectum. However, no PrPSc accumulation was 165 
demonstrated in the Ganglion cervicale craniale, Ganglion stellatum and the Vagus nerve. 166 
The preclinical scrapie-infected sheep carried either the PrPARQ/ARQ (9 cases) or the 167 
PrPARQ/AHQ (4 cases) genotype. There was no obvious correlation between the number of 168 
positive tissues and the age of the animal or between the quantity of accumulated PrPSc and 169 
the genotype of the sheep. Although a widespread distribution of PrPSc was detected in most 170 
animals, none of the 13 sheep was positive in every single sample.  171 
 172 
4. Discussion 173 
In this study 169 sheep carrying the susceptible genotypes and six goats out of a flock, 174 
which underwent a selective culling to eradicate scrapie, were analysed. This investigation 175 
revealed that 30% of these animals were preclinically scrapie-infected and that 7.4% of them 176 
were PrPSc -positive only at the peripheral sites but not in the brain stem, which is routinely 177 










tested. This prevalence is within the range of 5% to 30.3% previously reported in similar 178 
studies (Jeffrey et al., 2002; Thorgeirsdottir et al. 2002; Ersdal et al. 2003; Vascellari et al. 179 
2005; Gonzalez et al., 2006). The classical scrapie prevalence in a flock depends on different 180 
factors: a) length of time period after the introduction of the infection into the flock; b) 181 
husbandry measures (e.g. postpartal removal of the placentas as the most infectious tissues, 182 
separation of lambing ewes, frequency of pasture changes, general hygiene measures); c) 183 
genetic status (in terms of scrapie susceptibility) of the animals in the flock; d) differences in 184 
the scrapie strains (Andreoletti et al., 2001; Jeffrey et al., 2001).  185 
The origin of the scrapie infection in this flock, in which the oldest scrapie-infected 186 
sheep was born in 1998, is unknown. However, the large number of scrapie-infected sheep 187 
may reflect the fact that this flock has had a long scrapie history which was possibly started 188 
by the introduction of an infected animal from the outside. In this regard it is of particular 189 
interest that most of the sheep with a positive rapid test result are two years or younger, which 190 
corresponds to the reported changes in the age-genotype profile in flocks which have been 191 
infected for several years (Baylis et al., 2000). The last acquisition of ewes took place in 192 
1994, while rams were restocked from other flocks for many years. Interestingly, scrapie was 193 
diagnosed in a neighbourhood flock in 1979/1980, but the eradication measures taken at this 194 
time were not fully recorded. Little is known about the husbandry measures which were 195 
applied in this particular scrapie-affected flock.  196 
In our study, all affected animals were either PrPARQ/ARQ or PrPAHQ/ARQ carriers and no 197 
differences in the distribution of PrPSc were found between these groups. These results are in 198 
contrast to previous studies carried out in Scotland (Jeffrey et al., 2002) and Iceland 199 
(Thorgeirsdottir et al., 2002) in which these genotypes seemed to be more resistant to a 200 
scrapie infection. However, the results reported here are in accordance with the results from 201 
an outbreak in Italy (Vascellari et al., 2005). The most probable explanation for this difference 202 
is that scrapie strains with a bias towards different genotypes had been going round the flocks 203 










in question. All seven PrPARR heterozygous sheep were negative in our study. Although most 204 
of the sheep were at least four years or older (5/6), the low number of animals with this semi-205 
resistant genotype does not allow us to exclude that the scrapie agent targets genotypes with 206 
an age-dependent lower prevalence as shown in a previous study (Gonzalez et al., 2006). 207 
 All preclinically scrapie-infected sheep showed a marked and widespread distribution 208 
of PrPSc throughout the lymphoreticular system and in some parts of the peripheral nervous 209 
system. However, none of the animals was positive in every tissue sampled. In accordance 210 
with several studies most animals (n=11) showed an accumulation of PrPSc in the Peyer’s 211 
patches of the distal ileum and/or the draining lymph nodes, suggesting the intestine as the 212 
port of entry for the agent (Heggebo et al., 2000; van Keulen et al., 2002). Additionally, six of 213 
the sheep showed a clear staining reaction in the enteric nervous system as well as in the 214 
CMGC, indicating the subsequent spread to the CNS (van Keulen et al., 2000). In contrast, in 215 
two sheep (5, 11) no detectable amount of PrPSc was found in the intestine and the mesenteric 216 
lymph nodes. One possible explanation could be a direct neuroinvasion (Jeffrey et al., 2002). 217 
However, none of the neuronal tissues examined contained PrPSc depositions, whereas a 218 
strong immunostaining was seen in the tonsil and in the Ln. retropharyngealis lateralis. 219 
Therefore the oronasal cavity may have served as a port of entry in these two sheep. 220 
The current EU strategy for the active and passive surveillance of sheep TSEs is based 221 
on the testing of CNS samples. The results of the present study reveal that a better estimation 222 
of the “real” prevalence of scrapie-infected sheep can be obtained when LRS samples are 223 
examined as well.  224 
However, it must be noted that a diagnostic examination of the LRS alone (as 225 
suggested by Gonzalez et al., 2006) would lead to studies missing the large number of 226 
atypical scrapie cases which lack a PrPSc dissemination in the LRS (Gavier-Widen et al., 227 
2005). The same applies for sheep carrying the PrPARR haplotype. Therefore a combination of 228 










CNS and LRS testing is necessary to detect all clinical and preclinically scrapie-infected 229 
animals in affected flocks.     230 
 231 
5. Conclusion 232 
In conclusion, this study shows that a negative result of the rapid test on brain stem 233 
samples does not exclude the presence of PrPSc in peripheral tissues. In consequence, the 234 
actual prevalence of preclinical scrapie is significantly underestimated when it is only based 235 
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ptTable 1: Numbers, genotypes and age of all culled sheep and goats   
 
Number of sheep with genotypes Age (in years)*  Total  
number ARQ/ARR ARQ/ARQ ARQ/AHQ AHQ/ARQ VRQ/ARQ VRQ/ARR 0-1 1-2 2-3 3-4 > 4 



























goats 6 -- -- -- -- -- -- unknown 

















































1 + - +'* + - + + - - - - - - - ARQ/ARQ >4 
2 - + +'* + - + + - - - - - - - ARQ/ARQ >4 
3 + + + + + + + + - + - - - - ARQ/ARQ 2-3 
4 + - - - - - - - - - - - - - ARQ/ARQ 2-3 
5 - - + + - + + - - - - - - - ARQ/ARQ 2-3 
6 + + - - - + - + + + - - - - ARQ/ARQ 1-2 
7 + + + + + + + + + + - - - - ARQ/ARQ 1-2 
8 - + + + - - + - - - - - - - ARQ/ARQ 0-1 
9 - + + + - + + - - - - - - - ARQ/ARQ 0-1 
10 + + + + - + + + - + - - - - AHQ/ARQ 1-2 
11 - - + + - - - - - - - - - - AHQ/ARQ 1-2 










12 + - - - - - - + + + - - - - AHQ/ARQ 0-1 
13 + - - - - - - + - + - - - - AHQ/ARQ  
Total 8 7 9 9 2 8 8 6 3 6 0 0 0 0     
 
*   Lnn. mandibulares 
IPP  Peyer’s patches of the distal ileum  
RPLN  Retropharyngeal lymph node 
ENS  Enteric nervous system CMGC  Coeliac and mesenteric ganglion complex 
 
 











Figure 1:  
Hierarchical approach in the sample selection from culled sheep and goats that underwent a 
further immunohistochemical examination 
 
Figure 2: 
Distinct PrPSc immunolabelling in different tissues of sheep 
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